Clinical Trial Update: Vis-Rx Post-Market Evaluation

View source ↗

Summary

Completed post-market evaluation study of Vis-Rx sponsored by Gentuity, LLC, assessing its use in coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Vis-Rx

Snippet

Sponsor: Gentuity, LLC | Conditions: Coronary Artery Disease | Status: COMPLETED